Titan Biotech Share Price Today | Stock Price & Titan Biotech Share Screener
As of October 5, 2026, the live Titan Biotech share price (BSE: TITANBIO) is ₹383.20, down 2.12% from the previous close, with shares trading between ₹380.25 and ₹397.95 in today's trading session, and a 52-week range of ₹220.20–₹1,424.50. Check TITANBIO 52-week chart for the annual price range and momentum. Use the Titan Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Titan Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹61 and net income of ₹11, with EBITDA of ₹14, an operating margin of 21.0% and a profit margin of 18.0%.
Titan Biotech Share Price Chart
Track the current stock price of Titan Biotech with an interactive chart. Analyse TITANBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Titan Biotech stock quote in one place.
The quote of ₹383.20 sits between the 52-week low of ₹220.20 and the 52-week high of ₹1,424.50, and the latest session moved -2.12% from the previous close.
Titan Biotech Company Profile - Fundamental Screener
Screen Titan Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TITANBIO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE150C01029.
Company Details
Classification
Identifiers and Leadership
Titan Biotech Balance Sheet Screener
Screen TITANBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹214, up from ₹175 in 2025.
Latest statistics put total assets at ₹214 and shareholder funds at ₹182, with a leverage ratio of 0.03.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 214 | 175 | 157 | 135 | 108 | 101 | 76 | 65 | 57 | 52 |
| Current Assets | 85 | 80 | 73 | 68 | 64 | 59 | 44 | 35 | 29 | 30 |
| Fixed Assets | 62 | 57 | 52 | 36 | 35 | 34 | 31 | 29 | 14 | 13 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 6 | 4 | 4 | 4 | 5 | 9 | 14 | 15 | 20 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 182 | 153 | 134 | 110 | 86 | 73 | 42 | 34 | 26 | 24 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 173 | 145 | 125 | 102 | 78 | 61 | 31 | 24 | 17 | 15 |
Titan Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Titan Biotech income statement and profit fundamentals. Analyze TITANBIO quarterly results. Titan Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹61 and net profit was ₹11, equal to earnings per unit of ₹2.63, at an operating margin of 21%.
In that period expenses were ₹47, interest cost ₹0 and tax ₹2. The next period listed, 2026-Mar, shows revenue of ₹51 and net profit of ₹7.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 61 | 51 | 58 | 56 | 47 | 37 | 40 | 40 | 44 | 40 | 46 | 44 | 35 | 37 | 31 |
| Expenses | 47 | 39 | 46 | 45 | 38 | 31 | 33 | 32 | 35 | 33 | 35 | 35 | 27 | 30 | 26 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 14 | 12 | 12 | 11 | 10 | 6 | 6 | 8 | 9 | 8 | 11 | 9 | 8 | 7 | 4 |
| Operating Profit % | 21.00% | 20.00% | 19.00% | 17.00% | 19.00% | 13.00% | 13.00% | 19.00% | 19.00% | 18.00% | 23.00% | 20.00% | 23.00% | 19.00% | 14.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 13 | 10 | 11 | 9 | 8 | 5 | 5 | 7 | 8 | 6 | 10 | 8 | 7 | 6 | 4 |
| Tax | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 3 | 2 | 1 | 1 | 0 |
| Net Profit | 11 | 7 | 9 | 8 | 7 | 4 | 4 | 7 | 6 | 5 | 7 | 7 | 6 | 5 | 3 |
| EPS | 2.63 | 1.63 | 10.32 | 9.40 | 8.30 | 4.90 | 5.31 | 8.10 | 7.74 | 6.05 | 8.68 | 7.89 | 7.47 | 6.07 | 3.95 |
Titan Biotech Cash Flow Screener - Liquidity Fundamentals
Screen TITANBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹30, and net cash flow was an outflow of ₹4.
Over the same period, investing activities used ₹33 and financing activities used ₹2.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 30 | 20 | 21 | 21 | 22 | 19 | 6 | 6 | 2 | 0 |
| Investing Activities | -33 | -10 | -20 | -21 | -16 | -5 | -2 | -4 | -6 | -8 |
Financing and Net Cash | ||||||||||
| Financing Activities | -2 | -8 | -3 | -2 | -4 | -11 | -4 | 0 | 0 | 9 |
| Net Cash Flow | -4 | 2 | -2 | -2 | 2 | 4 | 0 | 1 | -3 | 1 |
Titan Biotech Shareholding Pattern Screener
See Titan Biotech shareholding pattern with promoter, FII, and DII holdings. Check Titan Biotech promoter holding and ownership changes for TITANBIO on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 55.78%, foreign institutions 0.00%, domestic institutions 0.03% and the public 27.72%, spread across 17,457 shareholders.
The shareholder count was 17,457 in 2026-Mar, compared with 18,671 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 55.78% | 55.78% | 55.88% | 55.88% | 55.78% | 55.78% | 55.88% | 55.88% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.03% | 0.01% | 0.01% | 0.03% | 0.03% | 0.03% | 0.23% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.72% | 28.02% | 29.20% | 29.44% | 29.65% | 29.74% | 30.06% | 30.11% |
| Other Holding | 16.47% | 16.19% | 14.91% | 14.65% | 14.54% | 14.45% | 13.84% | 14.01% |
| Shareholder Count | 17,457 | 18,671 | 16,370 | 16,328 | 16,040 | 16,367 | 15,876 | 15,850 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Titan Biotech. Titan Biotech dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.13%, compared with ₹2.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹2.00 and ₹2.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.50 | 0.13% |
| 2025-March | ₹2.00 | 0.44% |
| 2024-March | ₹2.00 | 2.37% |
| 2023-March | ₹1.80 | 1.70% |
| 2022-March | ₹1.50 | 3.81% |
| 2021-March | ₹1.50 | 2.86% |
| 2020-March | ₹1.00 | 2.69% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.75 | 8.33% |
| 2017-March | ₹0.75 | 5.96% |
Titan Biotech Stock Index Membership - Nifty & Sensex
See which indices include Titan Biotech stock. Check TITANBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Titan Biotech Market Events Screener - Corporate Actions
Get Titan Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Titan Biotech stock events that may affect TITANBIO share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Dividend dated September 22, 2026 and Quarterly Result Announcement dated August 13, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -6.86% |
| 2026-09-22 | 2026-09-22 | Dividend | ₹ 0.50 /share | -7.59% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -3.73% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 5.29% |
| 2026-02-20 | 2026-02-20 | Split | 2:10 | 32.89% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 10.81% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -7.75% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | 112.48% |
| 2025-09-19 | 2025-09-19 | Dividend | ₹ 2.00 /share | 102.73% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.29% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.55% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.10% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -4.87% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 14.27% |
| 2024-09-23 | 2024-09-24 | Dividend | ₹ 2.00 /share | 14.63% |
Titan Biotech Competitors Screener - Peer Stocks Comparison
Screen TITANBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 149,018 | 56.00 | 14,867 | 11.05% | 2,471 | 29.48 |
| SRF | 73,697 | 33.92 | 15,894 | 7.20% | 1,835 | 43.41 |
| Gujarat Fluorochemicals | 47,691 | 80.72 | 5,126 | 5.63% | 574 | 36.03 |
| Navin Fluorine International | 41,734 | 53.60 | 3,379 | 41.21% | 664 | 42.00 |
| Himadri Speciality Chemical | 33,562 | 42.51 | 4,832 | 3.60% | 755 | 45.08 |
| Aether Industries | 22,166 | 95.87 | 1,181 | 34.17% | 220 | 52.27 |
| Deepak Nitrite | 20,361 | 26.65 | 7,947 | -5.01% | 551 | 28.76 |
| Atul | 17,256 | 21.52 | 6,476 | 13.77% | 689 | 28.93 |
| Aarti Industries | 16,864 | 32.51 | 8,291 | 13.78% | 419 | 36.54 |
| Fine Organic Industries | 15,732 | 35.85 | 2,483 | 4.89% | 417 | 49.47 |
Titan Biotech Company Announcements - News & Reports Screener
Screen TITANBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 2, 2026.
The next most recent announcements are dated October 2, 2026 and October 1, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-02 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2026-10-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-26 | Closure of Trading Window | - |
| 2026-09-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-05 | Intimation Regarding Weblink To Access The Annual Report For FY 2025-26 And Notice Of The 34Th Annual General Meeting For Shareholders Whose Email Ids Are Not Registered | - |
| 2026-09-05 | Notice Of Thirty- Fourth (34Th) Annual General Meeting | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-03 | Intimation Of Record Date For The Purpose Of Final Dividend | - |
| 2026-09-03 | Fixation Of Annual General Meeting Date Record Date Book Closure Date And E-Voting Date | - |
| 2026-09-03 | Corporate Action-Fixes Book Closure For 34Th Annual General Meeting Of The Company | - |
| 2026-09-03 | Corporate Action-Board recommends Bonus Issue | - |
| 2026-09-03 | Board Meeting Outcome for Outcome Of Board Meeting Dated September 3 2026 | - |
| 2026-08-31 | Board Meeting Intimation for Considering Bonus Issue Draft AGM Notice Draft Directors Report Fix AGM Decide Cut Off Date E-Voting Dates Record Dates Books Closure And Any Other Items With The Permission Of Chair. | - |
| 2026-08-31 | Closure of Trading Window | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2026 | - |
| 2026-08-13 | Unaudited Financial Results For Quarter Ended June 2026 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹383.20, within a 52-week range of ₹220.20 to ₹1,424.50. The P/E ratio is 48.02 and the P/B ratio is 8.96, with earnings per unit of ₹7.23. Market capitalisation stands at ₹1,617.60 Cr and the dividend yield is 0.13%. The company operates in the Chemicals sector, in the Specialty Chemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.